Rapharma expands its immunosuppressants portfolio


Rapharma is launching Landotex® (INN lenalidomide) onto the Russian market. Landotex® is a Russian generic of lenalidomide, but it is not inferior to the original drug in quality, while more affordable economically. In the Russian Federation, the drug is included in the 14 Cost-Intensive Nosologies state program, and its procurement is arranged accordingly.

It is used in adults with multiple myeloma, myelodysplastic syndromes, follicular lymphoma, lymphoma from the cells of the mantle zone or basal border.

Rapharma pays a lot of attention to the quality of its products. It has its own pharmaceutical complex designed and built in accordance with the requirements of EU’s GMP requirements.

The company is proactive in supporting the development of Russian healthcare: it makes efforts to increase the availability of medicines for patients, regardless of their income.


Exit mobile version